Effect of Physical Exercise in Alzheimer Patients

Phase 3

Completed

• Conditions: Alzheimer Disease
• Interventions: Other: Aerobic exercise

• Registration Number: NCT01681602
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

Background: Current treatment for Alzheimer's disease (AD) is symptomatic and can only temporarily slow down progression.

Exercise has the potential to improve cognition, psychological symptoms, physical performance and quality of life, but evidence is scarce. Previous trials are short, often underpowered and involving home based light exercise programs. Most have included nursing homes residents with severe or undefined dementia. The aim of the ADEX trial is to establish whether exercise is effective in improving cognition, physical performance and quality of life as well as reducing the prevalence of psychological symptoms among AD patients.

Methods: The ADEX Trial is a multicentre, single-blind, randomized clinical trial. Based on power calculations the investigators plan to recruit 192 home-dwelling patients aged 50-90 years with mild to moderate AD. The participants will be randomly allocated into two groups: An intervention group attending 16 weeks of continuously supervised moderate aerobic exercise 1 hour three times a week and a control group only receiving usual care. The hypothesis is that aerobic exercise will improve physical function, the cognitive and daily functioning and quality of life in people with mild to moderate AS.

Blood sampling will be performed in all subjects to examine effects on biomarkers. A subgroup of the patients will also undergo MRI, PiB-PET and lumbar puncture to investigate structural changes and β-amyloid accumulation.

Further, a health-economic analysis will be performed.

Recruitment was started in January 2012. Last study visits are planned to be performed in January 2014 and results will be available in 2014. This RCT will contribute to evidence regarding the potential effects of a systematic program of physical exercise for patients with Alzheimer's disease.

Detailed Description

see protocol article

Study Timeline

• Study Start: 2012-01
• Study First Submitted: 2012-04-30
• Study First Submitted QC: 2012-09-05
• Study First Posted: 2012-09-10
• Primary Completion: 2014-01
• Study Completion: 2014-06
• Status Verified: 2014-11
• Last Update Submitted: 2014-11-28
• Last Update Posted: 2014-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Inclusion criteria are (table 1)
• Age between 50 and 90 years
• A score of 20 or more on the Mini Mental State Examination (MMSE)
• Imaging (CT or MR of cerebrum) consistent with AD
• Have a caregiver with regular contact to the participant (more than once a month) who is also willing to participate in the study
• In general good health allowing the participant to participate in physical exercise.
• At least 7 years of schooling and Danish speaking
• Visual acuity and hearing must permit neuropsychological testing.
• If the patient is receiving anti-dementia medication or mood stabilizing medication, these must have been given in stable doses for at least 3 months.

Exclusion Criteria

• Participation in aerobic exercise (moderate to hard intensity) more than 2 times a week on a regular basis.
• Any musculoskeletal or joint impairment that could interfere with completion of the study (significant joint problems, back pain or pain in arms and legs that provide problems with mobility in daily activities)
• Male participants with a combination of two or more of the following risk factors even if asymptomatic: smokers, hypertension and hypercholesterolemia
• Major neurologic (other than AD), cardiac or other medical diseases that constitutes a contraindication to physical activity. Stent operation or previous myocardial infarction is not an exclusion criteria if the participant has had a recent (within 3 months) normal exercise tests .
• Severe cerebro vascular disease judged from the CT or MR scans and remarkable hypertension defined as Systolic blood pressure >180 and diastolic >100
• Severe psychiatric disease, as well as alcohol or drug abuse within the last 2 years

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention group	Aerobic exercise	16 weeks of aerobic exercise

Primary Outcome Measures

Name	Time	Method
Symbol Digit Modalities Test	Change in score from baseline to 16 weeks

Secondary Outcome Measures

Name	Time	Method
Euro-qol-5D-5L (health related quality of life)	Change in score from baseline to 16 weeks
Astrand submaximal bicycle test for estimating VO2 max	Change in score from baseline to 16 weeks
NPI (psychological symptoms.)	Change in score from baseline to 16 weeks
Verbal fluency	Change in score from baseline to 16 weeks
Stroop	Change in score from baseline to 16 weeks
Self-efficacy scale	Change in score from baseline to 16 weeks
Changes in physical fitness	Change in score from baseline to 16 weeks	Timed up and go test (TUG), 10 m walk, 10m Dual-Task, 400m fast walking, Sit-to-stand (number in 30 sec.)(STS).
MMSE (Mini Mental State Examination)	Change in score from baseline to 16 weeks
Alzheimer's disease Assessment Scale - Cognitive section (ADAS-cog).	Change in score from baseline to 16 weeks

Trial Locations

Locations (1)

Danish Dementia Research Centre, Department of Neurology, Rigshospitalet.; 🇩🇰 Copenhagen, Copenhagen Ø, Denmark